Search results
2 dni temu · RAHWAY, N.J.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2024. “Our third-quarter results were strong, as we continue to make progress heading into 2025 and beyond," said Robert M. Davis, chairman and chief executive officer, Merck.
2 dni temu · Merck & Co posted higher-than-expected third-quarter earnings on Thursday on strong sales of its blockbuster cancer treatment Keytruda, but the U.S. drugmaker also flagged a second straight ...
1 dzień temu · Looking forward, Merck narrows its full-year sales forecast to between $63.6 billion and $64.1 billion, while expecting non-GAAP EPS to be in the range of $7.72 to $7.77. The company remains ...
2 dni temu · Here’s what Merck reported for the third quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: Earnings per share: $1.57 adjusted vs. $1.50 expected ...
9 paź 2024 · Check out the latest Merck news and stories! Learn more about the leading science and technology company here.
EXPLORE SOME OF OUR WORK AREAS. Be curious to step into our science and technology passion and find out below our most growing departments, sites and businesses. This is where curious and passionate people open their minds to drive the future of Electronics through innovations in material science.
Chcesz być częścią globalnej firmy medycznej? Dołącz do naszego zespołu w MSD Polska i pomóż nam ulepszać i ratować życie pacjentów na całym świecie.
